Hormonal Contraception Access Through Pharmacist Prescribing Implementation
Launched by EMPOWERX INC · Feb 11, 2025
Trial Information
Current as of July 04, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new software called HAPPI that aims to help pharmacists provide birth control services more effectively. The main questions the researchers want to answer are whether the HAPPI software makes it easier for pharmacists to offer these services and whether it helps patients access birth control more easily. To find this out, they will compare how pharmacists and patients manage these services with and without the use of the HAPPI software.
To participate, pharmacists need to be at least 18 years old and currently provide birth control services in a participating pharmacy. Patients also need to be 18 or older and seeking birth control services at a pharmacy that is part of the study. Both pharmacists and patients will use the HAPPI software during the trial, and there are no special health requirements to join. Although the trial is not yet recruiting participants, it aims to improve how birth control services are delivered and accessed in pharmacies, which could benefit many individuals seeking these services.
Gender
ALL
Eligibility criteria
- • PHARMACIST Participants
- Inclusion Criteria:
- • 18 years of age or older
- • Provide birth control services in a participating pharmacy
- • Use the HAPPI software to provide birth control services
- Exclusion Criteria:
- • None
- • PATIENT Participants
- Inclusion Criteria:
- • 18 years of age or older
- • Seek birth control services at a participating pharmacy
- • Use the HAPPI software to receive birth control services at a participating pharmacy
- Exclusion Criteria:
- • NONE
About Empowerx Inc
EmpowerX Inc. is a leading clinical trial sponsor dedicated to advancing innovative therapies for unmet medical needs. With a strong focus on patient-centric research, EmpowerX leverages cutting-edge technology and a collaborative approach to streamline clinical development processes. Our expert team, comprised of seasoned professionals from diverse scientific and regulatory backgrounds, is committed to delivering high-quality, data-driven results that enhance the safety and efficacy of new treatments. EmpowerX aims to empower both patients and healthcare providers through rigorous clinical trials that pave the way for transformative healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Del Mar, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported